The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | P | Antiparasitic products, insecticides and repellents | |
| 2 | P01 | Antiprotozoals | |
| 3 | P01C | Agents against leishmaniasis and trypanosomiasis | |
| 4 | P01CC | Nitrofuran derivatives |
| Code | Title | |
|---|---|---|
| P01CC01 | Nifurtimox | |
| P01CC02 | Nitrofural |
| Active Ingredient | Description | |
|---|---|---|
| Nifurtimox |
Nifurtimox is an antiprotozoal drug. It is used in pediatric patients for the treatment of Chagas disease (American Trypanosomiasis) caused by Trypanosoma cruzi. Nifurtimox exposure-response relationships and the time course of pharmacodynamics response are unknown. |
|
| Nitrofurazone |
|